Kaimen
Patients facing terminal diagnoses don't always lack options - they lack knowledge that options exist. Kaimen distributes medical intelligence and turns it into actionable access.
I need...
CAR-T CELL THERAPY
Access to China's six approved CAR-T treatments, including the world's first solid-tumor CAR-T. The same therapy at 35% of US costs - for patients told there are no options left.
kaimen.co/car-tCLINICAL TRIALS
China runs more CAR-T trials than any country. For patients who don't qualify for approved therapies, Kaimen navigates the active trial pipeline across pancreatic, liver, lung, and other cancers.
kaimen.co/trialsMEDICAL CARE
Dental implants, orthopedic surgery, and specialist procedures at 25-30% of Western costs. Lower stakes, higher volume, same standard of care.
kaimen.co/care